IVACAFTOR GLYCOSIDES, METHODS OF MAKING, AND USES THEREOF IN TREATING CYSTIC FIBROSIS

• 1. 作为囊性纤维化跨膜传导调节因子的调节剂的大环化合物、其药物组合物、它们在治疗囊性纤维化中的用途，以及它们的制备方法 [P] . 中国专利： CN112004817A . 2020-11-27
• 2. 异喹啉化合物，其制备方法及其在与β-半乳糖苷酶活性改变相关的病症中的治疗用途 [P] . 中国专利： CN110494432A . 2019-11-22
• 3. Methods for cystic fibrosis disease assessment and methods for treating anaerobic P. aeruginosa biofilms in cystic fibrosis disease [P] . 美国专利： US2004266749A1 . 2004-12-30

  机译： 评估囊性纤维化疾病的方法和治疗囊性纤维化疾病中的厌氧铜绿假单胞菌生物膜的方法

• 4. CARDIAC GLYCOSIDES TO TREAT CYSTIC FIBROSIS AND OTHER IL-8 DEPENDENT DISORDERS [P] . 欧洲知识产权局专利： EP1513403B1 . 2017-02-15

  机译： 糖苷可治疗囊性纤维化和其他IL-8相关疾病

• 5. Cardiac glycosides to treat cystic fibrosis and other IL-8 dependent disorders [P] . 美国专利： US9511083B2 . 2016-12-06

  机译： 心脏甙可治疗囊性纤维化和其他IL-8依赖性疾病

• 1. Investigation of the interaction between two phenylethanoid glycosides and bovine serum albumin by spectroscopic methods [J] . Ai-Zhi Wu, Chao-Zhan Lin, Ya-Jing Zhai, 药物分析学报（英文） . 2013,第001期
• 2. Inhalable Dry Powder Microparticles for Delivery of Bacteriophages to Treat Cystic Fibrosis Associated Bacterial Lung Infections [C] . Rachit Agarwal, Christopher Johnson, Andres J Garcia Society for Biomaterials annual meeting and exposition . 2015
• 3. Treating an N-glycosylation abnormality in airways with a cystic fibrosis transmembrane conductance regulator protein deficiency reduces Pseudomonas aeruginosa colonization; A hallmark symptom of cystic fibrosis [D] . Martino, Ashley Thomas 2007
• 4. Development of HPLC and LC-MS/MS methods for the analysis of ivacaftor its major metabolites and lumacaftor in plasma and sputum of cystic fibrosis patients treated with ORKAMBI or KALYDECO [O] . Elena K. Schneider, Felisa Reyes-Ortega, John W. Wilson, -1
• 5. MS1 VALIDATION OF MODELED 5-YEAR SURVIVAL OUTCOMES AMONG PATIENTS WITH CYSTIC FIBROSIS (CF) TREATED WITH THE CF TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATOR (CFTRM) IVACAFTOR USING US CF FOUNDATION PATIENT REGISTRY (USCFFPR) DATA [O] . L. Mcgarry, A. Lopez, C. Chandler, 2020

• 1. Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients [J] . Katherine Kutney ,Shannon B Donnola ,Chris A Flask . 世界肝病学杂志：英文版（电子版） . 2019,第12期
• 2. Comparison of two methods of measurement of maximal respiratory pressures in health and cystic fibrosis [J] . Theodore Dassios ,Anna Katelari ,Stavros Doudounakis . 生物医学工程（英文） . 2013,第8期
• 3. Role of vitamin D in cystic fibrosis and non-cystic fibrosis bronchiectasis [J] . Maria Moustaki ,Ioanna Loukou ,Kostas N Priftis . 世界临床儿科杂志 . 2017,第3期
• 4. Solitary Bone Cyst of the Proximal Humerus with a Concomitant Stiff Shoulder Treated with both Arthroscopic Capsular Release and Arthroscope-Assisted Resection of the Bone Cyst: A Case Report [J] . Akira Ando ,Masashi Koide ,Yoshihiro Hagiwara . 矫形学期刊（英文） . 2018,第3期
• 5. 透明质酸锌的制备方法和用途 [C] . 杨桂兰 ,郭学平 ,吕莉 . 中国药学会2008年全国多糖类药物研究与应用研讨会 . 2008
• 6. 救必应酸和救必应酸固体分散体制备方法及其抑制α-葡萄糖苷酶活性研究 [A] . 常艳茹 . 2018